Article
Computational drug repurposing for inflammatory bowel disease using genetic information
1 Jan 2019
Abstract excerpt
As knowledge of the genetics behind inflammatory bowel disease (IBD) has continually improved, there has been a demand for methods that can use this data in a clinically significant way. Genome-wide association analyses for IBD have identified 232 risk genetic loci for the disorder. While identification of these risk loci enriches our understanding of the underlying biology of the disorder, their identification...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.